Cravath’s London Office Moves to 100 Cheapside
August 22, 2023
Cravath represented the underwriter and the dealers in connection with the $1.6 billion registered secondary common stock offering of AmerisourceBergen Corporation in connection with the entrance by Walgreens Boots Alliance Holdings LLC, the selling stockholder, into a prepaid variable share forward transaction. AmerisourceBergen Corporation is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The transaction closed on August 8, 2023.
The Cravath team included partners D. Scott Bennett and C. Daniel Haaren and associates Joshua Kameel and Noa Ma on capital markets matters, partner Arvind Ravichandran and associates Sonia Katharani‑Khan and Clayton Hackney on tax matters, and senior attorney Annmarie M. Terraciano and associate Star S. Gulant on environmental matters.
Deals & Cases
December 01, 2025
Cravath represented the underwriters in connection with the $500 million registered senior notes offering of Polaris Inc. Polaris Inc. designs, engineers, manufactures and markets powersport vehicles and also designs and manufactures or sources parts, garments and accessories. The transaction closed on November 13, 2025.
Deals & Cases
December 01, 2025
Cravath represented the underwriters in connection with the $900 million registered senior notes offering of The Mosaic Company, the world’s leading producer and marketer of concentrated phosphate and potash crop nutrients. The transaction closed on November 13, 2025.
Deals & Cases
November 26, 2025
Cravath represented the underwriters in connection with the $500 million registered notes offering of Howmet Aerospace Inc., a leading global provider of advanced engineered solutions for the aerospace and transportation industries. The transaction closed on November 12, 2025.
Deals & Cases
November 18, 2025
Cravath represented funds managed by affiliates of Brevan Howard in connection with an investment in Ripple Labs, Inc., consisting of a private placement of Class A Common Stock, as part of Ripple’s $500 million strategic investment at a $40 billion valuation, led by funds managed by affiliates of Fortress Investment Group, affiliates of Citadel Securities, Pantera Capital, Galaxy Digital, Brevan Howard and Marshall Wace. The transaction closed on November 4, 2025.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.